CREWE ADVISORS LLC Adaptive Biotechnologies Corporation Transaction History

CREWE ADVISORS LLC portfolio value:

$426,000
portfolio value

CREWE ADVISORS LLC quarter portfolio value change:

-11.99%
quarter

Adaptive Biotechnologies Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -58K $7.12 59.85K
Q2 2022 share Increase +1.03% 613 shares -338K $8.09 59.85K
Q1 2022 share Increase +0.17% 100 shares -837K $13.88 59.23K
Q4 2021 share 0.00% 0 shares -351K $28.33 59.13K
Q3 2021 share 0.00% 0 shares -406K $33.99 59.13K
Q2 2021 share 0.00% 0 shares 35K $40.86 59.13K
Q1 2021 share 0.00% 0 shares -1.11M $40.26 59.13K
Q4 2020 share Decrease -22.20% -16.87K shares -199K $59.13 59.13K
Q3 2020 share Decrease -6.64% -5.41K shares -243K $48.63 76.00K
Q2 2020 share Decrease -12.45% -11.58K shares 1.35M $48.38 81.41K
Q1 2020 share Increase 0.00% 93K shares 2.58M $27.78 93K